Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 4.930
+0.300 (6.48%)
At close: Jun 3, 2026
Aqua Bio Technology ASA Revenue
In the year 2025, Aqua Bio Technology ASA had annual revenue of 7.53M NOK, down -30.73%. Aqua Bio Technology ASA had revenue of -6.84M in the quarter ending December 31, 2025.
Revenue
7.53M
Revenue Growth
-30.73%
P/S Ratio
10.14
Revenue / Employee
3.77M
Employees
2
Market Cap
76.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.53M | -3.34M | -30.73% |
| Dec 31, 2024 | 10.87M | -7.86M | -41.96% |
| Dec 31, 2023 | 18.74M | 11.58M | 161.63% |
| Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
| Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 128.37M |
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 15.58M |
| Nykode Therapeutics AS | 5.42M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
| Circio Holding ASA | 123.00K |
Aqua Bio Technology ASA News
- 4 weeks ago - Aqua Bio Technology ASA Annual report: H2 2025 - Filings
- 6 months ago - Aqua Bio Technology ASA Quarterly report: Q3 2025 - Filings
- 10 months ago - Aqua Bio Technology ASA Quarterly report: H1 2025 - Filings